LUMICKS: Funding, Investors & Team (Sep 2026)
LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells. Built upon innovative and Nobel Prize-winning technologies, such as optical tweezers (Nobel Prize for Physics 2018), and STED super-resolution (Nobel Prize for Chemistry 2014), our tools enable the understanding of life to the smallest detail. Our goal is to advance science and improve human health, by providing tools that unlock the measurement of forces and interactions in biology. For the first time ever, our unapparelled solutions can assist research by directly linking structural and ‘omics analysis to functional outcomes at both a molecular and a cellular level. This is achieved by applying and measuring forces around biological interactions, enabling the detailed real-time analysis of underlying biological mechanisms.
LUMICKS has raised $115M across 2 funding rounds on record, the most recent an undisclosed round of $21.9M announced in Oct 2024.
That round is above the $8.0M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
LUMICKS Company Profile and Key Stats
Latest funding round on record: Oct 2024.
LUMICKS Funding Rounds
LUMICKS raised $93.0M in a Series D announced in Apr 2021.
3.5 years later, an undisclosed round of $21.9M was announced in Oct 2024.
LUMICKS Founders and Leadership Team
Contact details for the LUMICKS team: 1 of 1 has an email address on file.
Start 14-day free trial →LUMICKS Funding Compared to Other Biotechnology Startups
LUMICKS' latest round of $21.9M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like LUMICKS in Biotechnology and Amsterdam
Companies Similar to LUMICKS
The Protein Brewery is a high-tech company that specializes in developing and making animal-free- based…
Leyden Labs aims to help people live their lives to the fullest. Its platform targets commonalities of viral…
Onward is creating an Implantable Neuro-stimulation System (INS) that includes real-time motion feedback and…
Scinvivo is a medical technology company. Scinvivo is involved in bladder cancer medical needs. They provide…
Revyve produces animal-free food ingredients from microorganisms. The company's premium ingredients include…
Merus is dedicated to creating superior treatments for cancer patients and potentially finding a cure. Our…
Salvia BioElectronics is dedicated to creating new neuromodulation devices to help treat migraines. They are…
We are a clinical-stage pharmaceutical company discovering and developing therapies targeting mitochondrial…
QurieGen is a biotechnology company that speeds up the process of finding and creating new drugs.
Protix Biosystems is a biometrics company that offers a range of products which enable its customers to…
QDI Systems is a startup company that engages in the development of advanced imaging devices for medical…
BIMINI Biotech, a startup established in 2019 in Leiden, The Netherlands, focuses on creating groundbreaking…
LUMICKS Funding FAQs
What does LUMICKS do?
LUMICKS is the leading supplier of dynamic single-molecule and cell avidity analysis instruments. Our instruments enable – for the first time – the analysis of complex dynamic details related to the behavior and interaction of single molecules and cells. Built upon innovative and Nobel Prize-winning technologies, such as optical tweezers (Nobel Prize for Physics 2018), and STED super-resolution (Nobel Prize for Chemistry 2014), our tools enable the understanding of life to the smallest detail. Our goal is to advance science and improve human health, by providing tools that unlock the measurement of forces and interactions in biology. For the first time ever, our unapparelled solutions can assist research by directly linking structural and ‘omics analysis to functional outcomes at both a molecular and a cellular level. This is achieved by applying and measuring forces around biological interactions, enabling the detailed real-time analysis of underlying biological mechanisms.
How much funding has LUMICKS raised?
LUMICKS has raised $115M across 2 rounds on record. The most recent is an undisclosed round of $21.9M announced in Oct 2024.
When did LUMICKS last raise funding?
LUMICKS' most recent funding round on record is an undisclosed round of $21.9M, announced in Oct 2024.
Who founded LUMICKS?
FundedIQ lists Olivier Heyning (Founder) at LUMICKS.
Where is LUMICKS headquartered?
LUMICKS is based in Amsterdam, Noord-Holland, Netherlands.
How many employees does LUMICKS have?
LUMICKS is in the 101-250 employee band.
How does LUMICKS' funding compare to other Biotechnology startups?
LUMICKS' latest round of $21.9M is above the $8.0M median round size for Biotechnology companies on FundedIQ across 4,179 tracked companies over the last two years.
About FundedIQ's LUMICKS Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for LUMICKS is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Every newly funded startup with its round, its investors and its founders: delivered weekly by email, or searchable in the app.
Alerts from $19/mo · Pro from $99/mo. Card required, nothing charged until day 15, and we email you 3 days before that.